Cidara Therapeutics Inc.

Free public records show Cidara Therapeutics Inc. in 2 of the markets we cover. It is not a key player in our research.

[1] ClinicalTrials.gov, Studies led by Cidara Therapeutics Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.

Public data

Free public data on Cidara Therapeutics Inc.

From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.

About our sources

Company facts

Website
cidara.com
Home country
United States
Stock listing
NASDAQ: CDTX
Legal name
CIDARA THERAPEUTICS, INC.
Type
Medicines

Source: Wikidata, Company record Q30268897. Retrieved 13 Nov 2026.

Source: GLEIF, Legal entity record, LEI 549300IHQ9Z7RI1X2D22. Retrieved 13 Nov 2026.

Source: SEC EDGAR, Company filings, CIK 1610618. Retrieved 13 Nov 2026.

Trials over time

Studies Cidara Therapeutics Inc. leads, by the year they started and their phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • No phase (devices, observational)

Source: ClinicalTrials.gov, Studies with Cidara Therapeutics Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.

Markets where public records show them

Markets we cover where free public records show Cidara Therapeutics Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.

Topics

The topics of the markets Cidara Therapeutics Inc. is in.

All topics

Search all reports for Cidara Therapeutics Inc. All companies